Ananth Sridhar
About Ananth Sridhar
Ananth Sridhar serves as the Senior Vice President of Corporate Development at BridgeBio, overseeing Eidos Therapeutics and Calcilytix Therapeutics since 2022. He has a diverse background in the biotechnology and pharmaceutical sectors, with experience at companies such as Regeneron Pharmaceuticals and Health Advances.
Work at BridgeBio
Ananth Sridhar currently serves as Senior Vice President of Corporate Development at BridgeBio, focusing on Eidos Therapeutics and Calcilytix Therapeutics. He has held this position since 2022. Prior to this role, he was Vice President of Corporate Development at BridgeBio from 2020 to 2022 and Senior Director of Corporate Development from 2018 to 2020. His work at BridgeBio involves strategic initiatives aimed at advancing the company's therapeutic development.
Education and Expertise
Ananth Sridhar holds a Master of Business Administration (MBA) from Harvard Business School. He also earned a Bachelor of Science degree with Honors in Chemical Engineering from Stanford University. His educational background provides a strong foundation for his roles in corporate development and strategic planning within the biotechnology sector.
Background
Ananth Sridhar has a diverse professional background in the biotechnology and pharmaceutical industries. He began his career as a Research Assistant at Stanford University School of Medicine, where he worked in the Department of Radiation Oncology from 2007 to 2010. He has held various roles at notable companies, including Regeneron Pharmaceuticals and Genentech, where he gained experience in product planning and business development.
Previous Experience
Before joining BridgeBio, Ananth Sridhar worked in several capacities across different organizations. He was an Analyst at Health Advances from 2010 to 2012 and participated in the Executive Leadership Program at Regeneron Pharmaceuticals from 2014 to 2016. Additionally, he served as an Advisor at Nanoly Bioscience from 2013 to 2020 and at VALIS Genomics from 2018 to 2020, contributing to strategic initiatives in these companies.
Career Progression
Ananth Sridhar's career has progressed through various roles in corporate development and strategic planning. He transitioned from an Analyst to senior leadership positions within BridgeBio, demonstrating a trajectory of increasing responsibility. His experience includes roles in business development, new product planning, and advisory positions, reflecting a comprehensive understanding of the biotechnology landscape.